US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cannabis Concept

246.51

+1.150.47%

Number of Gainers:2

Number of Losers:13

Number of Flat:1

PE:- -

High:248.13

Open:245.35

Low:241.34

Close:245.37

Volume:22.42M

Turnover:374.86M

Market Cap:60.73B

Float Cap:53.63B

Loading ...

T2 Metals Uncovers New High-Grade Gold Targets at Yukon’s Aurora Project

Aurora UK Alpha Boosts Treasury Stock with Share Buyback

Aurora Cannabis Rejects Curaleaf Offer as Inadequate, CEO Says Current Plan Will Pay Off

Teva Upgraded to Buy on Strengthening Autoimmune Pipeline and Validating Celiac Disease Data

Curaleaf Defends Aurora Bid, Citing Premium Offer and Stronger Cash Generation

Curaleaf says offer ‘best path to value creation’ for Aurora shareholders

Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live

AIM ImmunoTech Expands Ampligen Long COVID Patent Protection Across Europe, UK Through 2041

Veru CEO Steiner to Join Cantor Global Healthcare Conference Fireside Chat

Aurora Cannabis Board Rejects Curaleaf’s Hostile Bid, Urges Shareholders Not to Tender Shares

US-Listed Shares of Teva Pharmaceutical up 3.5% Premarket After Co's Immune Disorder Drug Meets Main Goal in Mid-Stage Trial

THOMSON REUTERS

Teva's Stock Jumps over 3% as Immune Disorder Drug Meets Main Goal in Mid-Stage Trial

GrowGeneration CEO Lampert to Present at H.C. Wainwright Global Investment Conference

GrowGeneration to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14-16, 2026

Teva Pharmaceutical Reports Positive Topline Data for Anti-IL-15 Drug in Celiac Disease

MT Newswires Live

Cronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes

Aurora Cannabis urges shareholders reject Curaleaf take-over bid

Teva: Tev '408 was Well-Tolerated with no Safety Signals Observed to Date

THOMSON REUTERS

Teva - Tev ‘408 Demonstrates Statistically Significant Prevention of Gluten-Induced Damage in Phase 2a Study

THOMSON REUTERS

Teva - Phase 2a Study Meets Primary Endpoint with Significant Prevention of Gluten-Induced Damage

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK4557/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4557","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","market":"US","secType":"PLATE","nameCN":"Cannabis Concept","latestPrice":246.51486,"timestamp":1789502399999,"preClose":245.36949,"halted":0,"volume":22423500,"delay":0,"changeRate":0.004668,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":1.14537,"latestTime":"09-15 16:00:00 EDT","open":245.34848,"high":248.12657,"low":241.34058,"amount":374864793.04824,"amplitude":0.027656,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.484041,"peRate":92.485057,"turnoverRate":0.007544,"increases":2,"decrements":13,"flats":1,"marketCap":60726663616.5,"floatMarketCap":53633624146.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","high":248.12657,"amplitude":0.027656,"preClose":245.36949,"low":241.34058,"pbRate":"3.484041","latestPrice":246.51486,"volume":22423500,"delay":0,"open":245.34848,"prevYearClose":226.48174,"prevWeekClose":244.1018,"prevMonthClose":240.6692,"prevQuarterClose":235.9952,"fiveDayClose":243.1504,"twentyDayClose":242.3446,"sixtyDayClose":220.1526,"secType":"PLATE","market":"US","turnoverRate":0.007544,"peRate":92.485057,"marketCap":60726663616.5,"floatMarketCap":53633624146.5,"timestamp":1789502399999,"nameCN":"Cannabis Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4557\",,,,undefined,":{"bkCode":"BK4557","up":2,"down":13,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4557\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664845651","title":"T2 Metals Uncovers New High-Grade Gold Targets at Yukon’s Aurora Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2664845651","media":"TIPRANKS","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664845651?lang=en_us&edition=fundamental","pubTime":"2026-09-03 01:02","pubTimestamp":1788368578,"startTime":"0","endTime":"0","summary":"The latest update is out from T2 Metals Corp. ( ($TSE:TWO) ). T2 Metals Corp. has reported encouraging initial results from 1,619 auger and soil sa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/t2-metals-uncovers-new-high-grade-gold-targets-at-yukons-aurora-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/t2-metals-uncovers-new-high-grade-gold-targets-at-yukons-aurora-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4110","BK4007","BK4557","MSOS","ACB","TWO","PICK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664435458","title":"Aurora UK Alpha Boosts Treasury Stock with Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2664435458","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664435458?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:27","pubTimestamp":1788366442,"startTime":"0","endTime":"0","summary":"An announcement from Aurora Investment Trust PLC ( ($GB:ARR) ) is now available. Aurora UK Alpha PLC has repurchased 25,000 ordinary shares at 252....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurora-uk-alpha-boosts-treasury-stock-with-share-buyback-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurora-uk-alpha-boosts-treasury-stock-with-share-buyback-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MSOS","BK4557","BK4007","ACB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843840","title":"Aurora Cannabis Rejects Curaleaf Offer as Inadequate, CEO Says Current Plan Will Pay Off","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843840","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843840?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:24","pubTimestamp":1788366240,"startTime":"0","endTime":"0","summary":"\" said Executive Chairman and Chief Executive Boris Jordan. \"We remain ready and willing to engage constructively with Aurora to discuss this offer at any point.\"Aurora's shares have been under pressure over the last year, falling 20% and recently traded at 5.62 Canadian dollars .Martin said that Curaleaf's offer is also opportunistically looking to use Aurora's $149 million liquidity to help absorb its own heavy debt load of over $1 billion. It also is structured to capitalize on Aurora's depressed share price, while Curaleaf's is high. \"From their standpoint, the timing is great,\" Martin said. \"We're trading at an all-time low and they're trading at an all-time high from a multiple standpoint.\"Aurora added the capped bid offers no meaningful change-of-control premium for its high-margin European operations and that it would subject investors to a share structure that would leave them with a 3.2% vote despite an equity stake of 7.7%.Aurora's board on Wednesday reiterated its confidenc","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4557","MSOX","MJ","WEED","ACB","TOKE","CNBS","YOLO","MSOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664884383","title":"Teva Upgraded to Buy on Strengthening Autoimmune Pipeline and Validating Celiac Disease Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2664884383","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664884383?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:15","pubTimestamp":1788365724,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Umer Raffat has maintained their bullish stance on TEVA stock, giving a Buy rating on August 31. Umer Raffat has given his Buy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/teva-upgraded-to-buy-on-strengthening-autoimmune-pipeline-and-validating-celiac-disease-data-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/teva-upgraded-to-buy-on-strengthening-autoimmune-pipeline-and-validating-celiac-disease-data-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4557","BK4584","BK4596","LU1983299246.USD","LU2324357040.USD","BK4588","TEVA","BK4559","BK4566","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664848612","title":"Curaleaf Defends Aurora Bid, Citing Premium Offer and Stronger Cash Generation","url":"https://stock-news.laohu8.com/highlight/detail?id=2664848612","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664848612?lang=en_us&edition=fundamental","pubTime":"2026-09-02 23:32","pubTimestamp":1788363176,"startTime":"0","endTime":"0","summary":"Curaleaf Holdings ( ($TSE:CURA) ) has issued an announcement. Curaleaf Holdings has publicly challenged Aurora Cannabis’ directors’ circular, reaff...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/curaleaf-defends-aurora-bid-citing-premium-offer-and-stronger-cash-generation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/curaleaf-defends-aurora-bid-citing-premium-offer-and-stronger-cash-generation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACB","MSOS","BK4557","MJ","CNBS","TOKE","BK4007","YOLO","MSOX","WEED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664486108","title":"Curaleaf says offer ‘best path to value creation’ for Aurora shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2664486108","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664486108?lang=en_us&edition=fundamental","pubTime":"2026-09-02 23:25","pubTimestamp":1788362710,"startTime":"0","endTime":"0","summary":"Curaleaf Holdings (CURLF) responded to “misleading statements” contained in Aurora Cannabis’ (ACB) Directors’ Circular and reiterated its belief th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/curaleaf-says-offer-best-path-to-value-creation-for-aurora-shareholders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/curaleaf-says-offer-best-path-to-value-creation-for-aurora-shareholders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNBS","MJ","BK4557","WEED","CURLF","ACB","MSOX","TOKE","YOLO","BK4007","MSOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664281081","title":"Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2664281081","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664281081?lang=en_us&edition=fundamental","pubTime":"2026-09-02 22:39","pubTimestamp":1788359970,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were tracking higher Wednesday morning, rising 0.72% to 3,003.68 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by biopharmaceutical company Zai Lab  and education company 17 Education & Technology Group , which climbed 6% and 4.8% respectively. They were followed by online entertainment service iQIYI  and fintech firm J and Friends , which advanced 2.4% and 2.5% respectively.The decliners from North Asia were led by fintech firm Jiayin Group  and electric vehicle maker NIO , which dropped 6.8% and 4.9% respectively. They were followed by internet and data center services provider VNET Group  and semiconductor company ASE Technology , which fell 2.5% and 0.5% respectively.From South Asia, the gainers were led by IT company Sify Technologies  and lender ICICI Bank , which rose 2.4% and 1% respectively. They were followed by telecommunications operator Telekomunikasi Indonesia , which increased 0.2%.The d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","LU2488822045.USD","BK4115","BK4534","LU0066902890.USD","LU0541502299.USD","TLK","BK4139","LU0181495838.USD","LU1048588211.SGD","LU0708995666.HKD","BK4531","LU1868838027.USD","LU0231203729.USD","LU1481012133.USD","BK4099","LU0541501648.USD","ZLAB","YQ","LU1046422090.SGD","BK4595","BK4596","IE00BYTNYM70.SGD","BK4552","LU0261950470.USD","BK4526","NIOG","EDOG","NIO","BK4116","LU0251144936.SGD","LU0264410563.USD","BK4170","BK4207","IE00B7N09G41.SGD","LU0531971678.HKD","BK4581","BK4557","LU0143863198.USD","LU1868837722.USD","09866","EVS.SI","BK4600","WIT","BK4585","BK4007","BK4607","LU1102505929.USD","09688","LU0248272758.USD","LU0197229882.USD","LU0307460401.USD","BK4555","BK4504","BK4166","LU1868837565.USD","LU0828237940.HKD","LU0348744763.USD","RDY","BK4134","JF","LU0821914370.USD","BK4108","BK4535","IE00B0JY6M65.USD","CAN","LU0052750758.USD","LU1267930656.SGD","BK4204","LU1805238398.USD","BK4141","BK4548","BK4089","NIO.SI","LU0048575426.USD","LU0823039010.USD","ASX","IQ","SIFY","LU0143863784.USD","LU0708995583.HKD","LU0261947096.USD","LU0164881194.USD","LU1048596156.SGD","LU0536402901.SGD","LU0048597586.USD","BK4543","LU0251143458.SGD","LU0823038988.USD","LU0320764599.SGD","JFIN","BK4588","BK4509","LU1102505762.USD","VNET","LU0072462343.USD","IBN","SG9999004220.SGD","LU0287143357.SGD","BK4532","BK4574","BK4510","BK4523"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000811","title":"AIM ImmunoTech Expands Ampligen Long COVID Patent Protection Across Europe, UK Through 2041","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000811","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000811?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:43","pubTimestamp":1788353000,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech expands Ampligen Long COVID patent protection across Europe, UK through 2041AIM ImmunoTech expanded Ampligen patent protection in Europe and the UK for treating Long COVID, with coverag","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL26vWd3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","BK4557","SG9999014021.USD","BK4585","AIM","IE00BQXX3F31.USD","SG9999014039.USD","IE00BN0W2W23.USD","SG9999014005.SGD","BK4112","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2210149790.SGD","BCDF","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4139","SG9999014013.SGD","NDAQ","LU2095319765.USD","IE00BQXX3D17.EUR","BK4588","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811447","title":"Veru CEO Steiner to Join Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811447","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811447?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:32","pubTimestamp":1788352326,"startTime":"0","endTime":"0","summary":"Veru CEO Steiner to join Cantor Global Healthcare Conference fireside chatVeru will join the 2026 Cantor Global Healthcare Conference in New York on Sept. 9, 2026.CEO Mitchell Steiner is scheduled for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5hC4BF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BCDF","SG9999014021.USD","IE00BN0W2T93.GBP","LU2095319765.USD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4112","BK4585","NDAQ","IE00BQXX3C00.GBP","BK4557","IE00BKPKM429.USD","LU0314104364.USD","SG9999014013.SGD","BK4584","BK4588","IE00BN0W2W23.USD","IE00BQXX3F31.USD","LU2210149790.SGD","BK4007","BK4183","SG9999014039.USD","VERU","IE00BQXX3D17.EUR","LU2210150020.SGD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811099","title":"Aurora Cannabis Board Rejects Curaleaf’s Hostile Bid, Urges Shareholders Not to Tender Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811099","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811099?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:27","pubTimestamp":1788352037,"startTime":"0","endTime":"0","summary":"An update from Aurora Cannabis ( ($TSE:ACB) ) is now available. On September 2, 2026, Aurora Cannabis urged its shareholders to reject a hostile, u...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aurora-cannabis-board-rejects-curaleafs-hostile-bid-urges-shareholders-not-to-tender-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aurora-cannabis-board-rejects-curaleafs-hostile-bid-urges-shareholders-not-to-tender-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOKE","ACB","YOLO","MSOX","BK4007","CNBS","MJ","WEED","BK4557","MSOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664190188","title":"US-Listed Shares of Teva Pharmaceutical up 3.5% Premarket After Co's Immune Disorder Drug Meets Main Goal in Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664190188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664190188?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:10","pubTimestamp":1788351042,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U12J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4584","LU1983299246.USD","BK4559","TEVA","BK4007","BK4585","BK4557","BK4596","BK4566","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664581946","title":"Teva's Stock Jumps over 3% as Immune Disorder Drug Meets Main Goal in Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664581946","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664581946?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:07","pubTimestamp":1788350831,"startTime":"0","endTime":"0","summary":"Teva's immune disorder drug meets main goal in mid-stage trialSept 2 (Reuters)-Israeli drugmaker Teva Pharmaceutical IndustriesTEVA.TA,TEVA.Nsaid on Wednesday its experimental drug helped prevent glut","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U0ZO:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Teva's Immune Disorder Drug Meets Main Goal in Mid-Stage Trial","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4584","IHE","BK4557","LU1983299246.USD","PBE","TEVA","LU2324357040.USD","BK4566","BK4585","BK4596","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819295","title":"GrowGeneration CEO Lampert to Present at H.C. Wainwright Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819295","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819295?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:02","pubTimestamp":1788350521,"startTime":"0","endTime":"0","summary":"GrowGeneration CEO Lampert to present at H.C. Wainwright Global Investment ConferenceGrowGeneration will present virtually at the H.C. Wainwright 28th Annual Global Investment Conference on Sept. 14-1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL4Hnsz1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","BK4588","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2095319765.USD","SG9999014039.USD","BK4112","BCDF","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014013.SGD","SG9999014021.USD","SG9999014005.SGD","NDAQ","BK4557","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","IE00BN0W2W23.USD","GRWG","BK4585","BK4083","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664190418","title":"GrowGeneration to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14-16, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664190418","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664190418?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350400,"startTime":"0","endTime":"0","summary":"DENVER, Sept.  02, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG)(“GrowGeneration,” “GrowGen” or “the Company”), one of the nation’s largest suppliers of specialty products for controlle","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355064/0/en/growgeneration-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference-on-september-14-16-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4083","BK4557","GRWG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664638819","title":"Teva Pharmaceutical Reports Positive Topline Data for Anti-IL-15 Drug in Celiac Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664638819","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664638819?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:51","pubTimestamp":1788349900,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical's  investigational anti-IL-15 antibody TEV '408 met the primary endpoint in an ongoing Phase 2a study in adults with celiac disease, the company said Wednesday.The company said a single subcutaneous dose of TEV '408 demonstrated statistically significant and clinically meaningful prevention of gluten-induced intestinal damage versus placebo at week 8.TEV '408 was well tolerated with no emerging safety signals, and additional analyses are underway, with further data expected to be presented at a future scientific meeting, Teva added.Teva Pharmaceutical shares were up 4.8% in premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","BK4557","BK4585","BK4007","LU1983299246.USD","BK4584","TEVA","BK4596","BK4566","BK4559","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664781953","title":"Cronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes","url":"https://stock-news.laohu8.com/highlight/detail?id=2664781953","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664781953?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:30","pubTimestamp":1788348600,"startTime":"0","endTime":"0","summary":"TORONTO, Sept.  02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is expanding its lineup of edible multipacks with the SOURZ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355030/0/en/cronos-brand-spinach-expands-its-best-selling-lineups-of-edibles-and-vapes.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRON","BK4557","YOLO","BK4007","MJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664537816","title":"Aurora Cannabis urges shareholders reject Curaleaf take-over bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2664537816","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664537816?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:15","pubTimestamp":1788347720,"startTime":"0","endTime":"0","summary":"Aurora Cannabis (ACB) urged shareholders to reject the unsolicited take-over bid from Curaleaf (CURLF), warning that the Hostile Bid would put Auro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aurora-cannabis-urges-shareholders-reject-curaleaf-take-over-bid-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aurora-cannabis-urges-shareholders-reject-curaleaf-take-over-bid-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["YOLO","MJ","TOKE","MSOX","ACB","BK4007","WEED","BK4557","CURLF","CNBS","MSOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815493","title":"Teva: Tev '408 was Well-Tolerated with no Safety Signals Observed to Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815493","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815493?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:03","pubTimestamp":1788346991,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U0FJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4559","BK4566","BK4007","LU2324357040.USD","BK4584","BK4588","BK4596","BK4585","LU1983299246.USD","TEVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815456","title":"Teva - Tev ‘408 Demonstrates Statistically Significant Prevention of Gluten-Induced Damage in Phase 2a Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815456","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815456?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:03","pubTimestamp":1788346991,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U0FJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4585","LU1983299246.USD","TEVA","LU2324357040.USD","BK4557","BK4559","BK4588","BK4584","BK4596","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664431815","title":"Teva - Phase 2a Study Meets Primary Endpoint with Significant Prevention of Gluten-Induced Damage","url":"https://stock-news.laohu8.com/highlight/detail?id=2664431815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664431815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:03","pubTimestamp":1788346991,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U0FJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4585","LU1983299246.USD","LU2324357040.USD","BK4588","BK4557","TEVA","BK4559","BK4566","BK4596","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":89,"code":"91000000","status":"200"}]}}